Ameriprise’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-168,646
| Closed | -$3.03M | – | 3839 |
|
|
2020
Q2 | $3.03M | Buy |
168,646
+157,714
| +1,443% | +$2.19M | ﹤0.01% | 2391 |
|
|
2020
Q1 | $78K | Sell |
10,932
-13,949
| -56% | -$174K | ﹤0.01% | 3557 |
|
|
2019
Q4 | $593K | Sell |
24,881
-5,085
| -17% | -$140K | ﹤0.01% | 3274 |
|
|
2019
Q3 | $804K | Sell |
29,966
-23,226
| -44% | -$652K | ﹤0.01% | 3107 |
|
|
2019
Q2 | $1.44M | Sell |
53,192
-25,115
| -32% | -$788K | ﹤0.01% | 2915 |
|
|
2019
Q1 | $2.72M | Buy |
78,307
+45,509
| +139% | +$1.31M | ﹤0.01% | 2594 |
|
|
2018
Q4 | $640K | Buy |
+32,798
| New | +$674K | ﹤0.01% | 3114 |
|
|
2018
Q3 | – | Sell |
-5,783
| Closed | -$218K | – | 3814 |
|
|
2018
Q2 | $218K | Buy |
+5,783
| New | +$221K | ﹤0.01% | 3462 |
|
|
2018
Q1 | – | Sell |
-32,000
| Closed | -$1.56M | – | 3734 |
|
|
2017
Q4 | $1.56M | Buy |
32,000
+528
| +2% | +$26.7K | ﹤0.01% | 2777 |
|
|
2017
Q3 | $1.7M | Buy |
31,472
+98
| +0.3% | +$5.75K | ﹤0.01% | 2694 |
|
|
2017
Q2 | $1.76M | Buy |
+31,374
| New | +$1.26M | ﹤0.01% | 2668 |
|
|
2016
Q1 | – | Sell |
-87,693
| Closed | -$4.51M | – | 3923 |
|
|
2015
Q4 | $4.51M | Buy |
87,693
+12,246
| +16% | +$594K | ﹤0.01% | 2082 |
|
|
2015
Q3 | $3.22M | Buy |
75,447
+33,464
| +80% | +$1.61M | ﹤0.01% | 2310 |
|
|
2015
Q2 | $1.91M | Buy |
+41,983
| New | +$1.69M | ﹤0.01% | 2788 |
|
|
2013
Q4 | – | Sell |
-604
| Closed | -$16K | – | 5520 |
|
|
2013
Q3 | $16K | Hold |
604
| – | – | ﹤0.01% | 4580 |
|
|
2013
Q2 | $15K | Buy |
+604
| New | +$12K | ﹤0.01% | 4505 |
|
Ameriprise's PTLA Position: Q3 2020 in Review
Ameriprise sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 168,646 shares — an estimated $3.03M sold.
Ameriprise first reported a position in PTLA in Q2 2013 and held it in 16 quarters. The position peaked at $4.51M in Q4 2015. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Ameriprise reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Ameriprise sold 168,646 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3.03M.
- Ameriprise first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 16 quarters.
- Ameriprise's Portola Pharmaceuticals, Inc. position peaked at $4.51M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Ameriprise's 13F filing for Q3 2020, filed 16 Nov 2020.